A team of researchers recently coordinated a series of international workshops aimed at enhancing chemical research security and fostering collaboration among scientists and academic researchers from both countries.
The Pacific Northwest Association of Toxicologists (PANWAT) presented its annual Toxicology Achievement Award to Katrina Waters at the Society of Toxicology Pacific Northwest Chapter Meeting, held in Lynnwood, Washington, on September 30th.
PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.
With the launch of a large research barge, PNNL and collaborators took another significant step to improve offshore wind forecasting that will lower risk and cost associated with offshore wind energy development.
Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.
Researchers seek to bring down costs, address potential environmental risks and maximize the benefits of harnessing wind energy above the deep waters of the Pacific.
The nation is closer to its offshore wind energy goals than ever before, but better wind forecasting is still needed. To address this challenge, PNNL and collaborators are charting a new course with help from novel technology.
PNNL had a significant presence at October’s North American Wind Energy Academy/WindTech 2023 Conference in Denver, Colorado. Thirteen PNNL wind experts participated in various capacities.
PNNL researchers helped design and conduct an international exercise hosted by the Ministry of Finance of Finland to help improve financial sector resilience.
Floating offshore wind farms could potentially triple the Pacific Northwest's wind power capacity while offsetting billions of dollars in costs for utilities, ratepayers, insurance companies, and others.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.
